Exchange: NYSE·Updated 04:54 PM EDT
BMY logo

BMY Bristol-Myers Squibb Co.

$62.85
$1.36
(2.21%)
Today
Closed $62.86
$0.015
(0.02%)
After Hours
EarningsOct 29
Mkt Cap$125.63B
Vol10.03M

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
28

Bearish Sentiment

How do you feel about BMY?

peloswing
$BMY Bristol Myers Squibb on clear support here around $63. HSBC price target raised from $60 to $65 ⬆️
1
DonCorleone77
$BMY Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study Bristol Myers Squibb presented results from the EXPLORER-LTE cohort of the MAVA-LTE study in a late-breaker presentation at the European Society of Cardiology, ESC, Congress 2026 in Munich, Germany. These data add to the understanding that the effects of Camzyos are sustained for up to five years with continuous, consistent treatment. Additional presentations at ESC Congress from COLLIGO-HCM, a global retrospective real-world data study, add to the real-world evidence supporting Camzyos, helping inform treatment decisions for people living with the condition.
1
OnlyFibs
$BMY | Snapshot 📊💊 • Business: Premier global biopharmaceutical leader specializing in innovative therapies across oncology, hematology, immunology, and cardiovascular diseases. • Financial Health & Pipeline: Strong dividend yield and stable free cash flow driving strategic pipeline acquisitions and late-stage clinical trial execution.• Bias & Conviction: Pullback Support Watch | Moderate Conviction (Watching for stabilization at $62.04 support for a continuation entry). 🎯 Key Levels: 🐂 Bull Trigger: $63.75 / $65.67 🚀 Targets: $65.67 / $67.00 / $68.64 🛡️ Support: $62.27 / $62.04 ⚠️ Risk: $60.00 / $58.09 🔥 Options Flow: • 🟢 06/17/2027 $65.0 Call ($227.5K Block | +2.56% OTM) • 🟢 06/17/2027 $70.0 Call ($74.2K Sweep | +9.26% OTM) • 🔴 01/21/2028 $55.0 Put ($163.8K Block | -14.25% OTM) • 🟢 10/16/2026 $65.0 Call ($33.8K Sweep | +0.98% OTM)
Equibles
$BMY This one turned up on Equibles. Bristol Myers Squibb Co EVP,Chief Med Offr,Head of Dev Massacesi Cristian reported selling 6,249 BMY shares on September 9, 2026, worth about $403.5 thousand, in a non-derivative Form 4.

Advertisement|Remove ads.